In the most recent study from 2023, which recruited 44 adolescents with PCOS and 44 adolescents without PCOS, the authors also observed no difference in apelin concentration between the control and study groups or its association with insulin resistance (80). The gene discussed is APLN; the disease is polycystic ovary syndrome.